BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2934633)

  • 1. The Walter Reed staging classification for HTLV-III/LAV infection.
    Redfield RR; Wright DC; Tramont EC
    N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
    McCray E
    N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
    Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
    Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
    J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
    N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
    N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
    Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
    N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
    Otu AA
    J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virologic studies in a case of transfusion-associated AIDS.
    Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P
    N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
    Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
    Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts.
    Lazzarin A; Negri C; Tambussi G; Saracco A; Galli M; Crocchiolo P; Irato L; Castagna A; Moroni M
    J Clin Lab Immunol; 1988 Apr; 25(4):157-60. PubMed ID: 2971807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
    Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
    N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.